Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Participatory Medicine

Date Submitted: Feb 8, 2026
Date Accepted: Oct 9, 2026

The final, peer-reviewed published version of this preprint can be found here:

Gamified Self-Care Mobile App for Lifestyle Support in Children With Leukemia: Development and Randomized Controlled Trial

Karimi F, Behnam Vashani H, Aghebati N, Pourghaznein T, Rajabpour M

Gamified Self-Care Mobile App for Lifestyle Support in Children With Leukemia: Development and Randomized Controlled Trial

J Particip Med 2026;18:e93106

DOI: 10.2196/93106

Gamified Self-Care Mobile Application for Lifestyle Support in Children with Leukemia: Development and Randomized Controlled Trial

  • Fatemeh Karimi; 
  • Hamidreza Behnam Vashani; 
  • Nahid Aghebati; 
  • Tayebeh Pourghaznein; 
  • Mohammad Rajabpour

ABSTRACT

Background:

Chemotherapy-related complications substantially disrupt daily functioning and lifestyle behaviors in children with leukemia. Mobile health and gamified educational technologies may facilitate engagement and improve self-care practices in pediatric patients.

Objective:

This study aimed to design, validate, and evaluate the effectiveness of a gamified self-care mobile application on lifestyle among children with leukemia undergoing chemotherapy.

Methods:

This study was conducted in two sequential phases during 2022–2023 in Mashhad, Iran. In Phase I, a gamified self-care mobile application was designed and validated through literature review, content development based on evidence-based pediatric oncology guidelines, expert evaluation, and technical testing. Content validity was confirmed by multidisciplinary specialists, and application quality was assessed using the Mobile Application Rating Scale (MARS). In Phase II, a parallel-group randomized controlled trial was performed among 60 children aged 7–12 years undergoing chemotherapy at Dr. Sheikh Pediatric Hospital. Participants were randomly assigned to intervention (application + routine education) or control (routine education only) groups for 8 weeks. Lifestyle behaviors were assessed at baseline and post-intervention using the School-Age Children Lifestyle Questionnaire. Data were analyzed using independent and paired t-tests and non-parametric equivalents.

Results:

The developed gamified application demonstrated acceptable content validity and quality scores on MARS. Fifty-nine participants completed the trial. After 8 weeks, the intervention group showed significantly higher total lifestyle scores than controls (p=0.003). Within-group improvement was also significantly greater in the intervention group compared with the control group (p<0.001).

Conclusions:

A theory-informed and validated gamified self-care mobile application significantly improved lifestyle behaviors among children with leukemia undergoing chemotherapy. Integrating evidence-based mobile health tools into pediatric oncology nursing care may enhance self-management and promote healthier lifestyles in this vulnerable population. Clinical Trial: This study was registered at the Iranian Registry of Clinical Trials (IRCT) with the registration number IRCT20211007052692N2.


 Citation

Please cite as:

Karimi F, Behnam Vashani H, Aghebati N, Pourghaznein T, Rajabpour M

Gamified Self-Care Mobile App for Lifestyle Support in Children With Leukemia: Development and Randomized Controlled Trial

J Particip Med 2026;18:e93106

DOI: 10.2196/93106

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.